Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.067 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |